In the last trading session, 1.0 million shares of the Allarity Therapeutics Inc (NASDAQ:ALLR) were traded, and its beta was -0.10. Most recently the company’s share price was $0.73, and it changed around $0.0 or 0.84% from the last close, which brings the market valuation of the company to $12.44M. ALLR currently trades at a discount to its 52-week high of $120.00, offering almost -16338.36% off that amount. The share price’s 52-week low was $0.61, which indicates that the current value has risen by an impressive 16.44% since then. We note from Allarity Therapeutics Inc’s average daily trading volume that its 10-day average is 1.28 million shares, with the 3-month average coming to 2.34 million.
Allarity Therapeutics Inc stock received a consensus recommendation rating of Hold, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended ALLR as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Allarity Therapeutics Inc is expected to report earnings per share of 0 for the current quarter.
Allarity Therapeutics Inc (NASDAQ:ALLR) trade information
Instantly ALLR has showed a green trend with a performance of 0.84% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.8400 on recent trading dayincreased the stock’s daily price by 13.1%. The company’s shares are currently down -37.50% year-to-date, but still down -7.57% over the last five days. On the other hand, Allarity Therapeutics Inc (NASDAQ:ALLR) is -19.02% down in the 30-day period. We can see from the shorts that 1.2 million shares have been sold at a short interest cover period of 0.39 day(s).
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 84.72%.
ALLR Dividends
Allarity Therapeutics Inc’s next quarterly earnings report is expected to be released on 2024-Nov-13.
Allarity Therapeutics Inc (NASDAQ:ALLR)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 4.38% of Allarity Therapeutics Inc shares, and 0.61% of them are in the hands of institutional investors. The stock currently has a share float of 0.64%.
Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund were the top two Mutual Funds as of Feb 28, 2025 . The former held 7.11 shares worth $5201.0, making up 0.04% of all outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held roughly 3.3 shares worth around $2410.0, which represents about 0.02% of the total shares outstanding.
